Tenon Medical, Inc.
General ticker "TNON" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $480.9K (TTM average)
Tenon Medical, Inc. does not follow the US Stock Market performance with the rate: -3.4%.
Estimated limits based on current volatility of 2.2%: low 0.79$, high 0.83$
Factors to consider:
- Total employees count: 21 (-4.5%) as of 2023
- Top business risk factors: Operational and conduct risks, Market competition, Third-party risks, Reputation and brand risks, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.66$, 2.08$]
- 2026-12-31 to 2027-12-31 estimated range: [0.60$, 1.90$]
Financial Metrics affecting the TNON estimates:
- Positive: with PPE of -0.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -138.88 <= 0.07
- Positive: 42.60 < Shareholder equity ratio, % of 46.84 <= 64.25
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term TNON quotes
Long-term TNON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.93MM | $3.28MM | $3.94MM |
| Operating Expenses | $18.66MM | $17.04MM | $16.74MM |
| Operating Income | $-15.73MM | $-13.77MM | $-12.79MM |
| Non-Operating Income | $0.15MM | $0.09MM | $0.24MM |
| Interest Expense | $0.02MM | $0.03MM | $0.00MM |
| R&D Expense | $3.16MM | $2.60MM | $2.15MM |
| Income(Loss) | $-15.58MM | $-13.67MM | $-12.56MM |
| Profit(Loss)* | $-15.58MM | $-13.67MM | $-12.56MM |
| Stockholders Equity | $0.78MM | $5.97MM | $5.04MM |
| Inventory | $0.55MM | $0.61MM | $1.05MM |
| Assets | $6.34MM | $9.84MM | $10.76MM |
| Operating Cash Flow | $-12.18MM | $-9.88MM | $-10.74MM |
| Capital expenditure | $0.36MM | $0.19MM | $0.27MM |
| Investing Cash Flow | $6.14MM | $-0.19MM | $-1.02MM |
| Financing Cash Flow | $6.30MM | $14.12MM | $8.99MM |
| Earnings Per Share** | $-68.64 | $-11.26 | $-1.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.